These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Methods and practices used in incident analysis in the Finnish nuclear power industry. Suksi S J Hazard Mater; 2004 Jul; 111(1-3):73-9. PubMed ID: 15231350 [TBL] [Abstract][Full Text] [Related]
7. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
9. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
10. A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis. Mussen F; Salek S; Walker S Pharmacoepidemiol Drug Saf; 2007 Jul; 16 Suppl 1():S2-S15. PubMed ID: 17546573 [TBL] [Abstract][Full Text] [Related]
12. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
13. Protecting people against radiation exposure in the event of a radiological attack. A report of The International Commission on Radiological Protection. Valentin J; Ann ICRP; 2005; 35(1):1-110, iii-iv. PubMed ID: 16164984 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
15. The role of scientific evidence of risks and benefits in determining risk management policies for medications. Andrews E; Dombeck M Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):599-608. PubMed ID: 15362082 [TBL] [Abstract][Full Text] [Related]
16. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration]. Baumann M; Trincard M Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539 [TBL] [Abstract][Full Text] [Related]
17. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
18. A heuristic risk assessment technique for birdstrike management at airports. Allan J Risk Anal; 2006 Jun; 26(3):723-9. PubMed ID: 16834629 [TBL] [Abstract][Full Text] [Related]
19. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
20. Implementing the Precautionary Principle: incorporating science, technology, fairness, and accountability in environmental, health, and safety decisions. Ashford NA Int J Occup Med Environ Health; 2004; 17(1):59-67. PubMed ID: 15212207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]